bildliche Darstellung
Schuppenflechte

Ursachen, Symptome, Diagnose & Behandlung

<p>Ekzem</p>

Ekzem

Ekzeme sind Entzündungen der Haut. Es gibt 3 verschiedene Formen

<p>Medikamente gegen Neurodermitis</p>

Medikamente gegen Neurodermitis

Welche Medikamente bei Neurodermitis helfen, hängt von der Stufe der Erkrankung ab. Ein Überblick über Cortison und alternative Wirkstoff

<p>Symptom Juckreiz</p>

Symptom Juckreiz

Juckreiz ist eine Missempfindung der Haut, die flächendeckend, chronisch & örtlich auftreten kann. Er kann auf ernste Grunderkrankungen hindeuten

Quellen

  1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. The Journal of investigative dermatology. 2013;133(2):377-85.
  2. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017;31(2):205-12.
  3. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. Journal of the American Academy of Dermatology. 2009;60(3):394-401.
  4. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature genetics. 2010;42(11):985-90.
  5. Mahil SK, Capon F, Barker JN. Genetics of psoriasis. Dermatologic clinics. 2015;33(1):1-11.
  6. Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2010;63(6):1058-69.
  7. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Archives of dermatology. 1999;135(12):1490-3.
  8. Qureshi AA, Dominguez PL, Choi HK, Han J, Curhan G. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Archives of dermatology. 2010;146(12):1364-9.
  9. Higgins E. Alcohol, smoking and psoriasis. Clinical and experimental dermatology. 2000;25(2):107-10.
  10. van der Velden HM, Klaassen KM, van de Kerkhof PC, Pasch MC. Fingernail psoriasis reconsidered: a case-control study. Journal of the American Academy of Dermatology. 2013;69(2):245-52.
  11. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. The British journal of dermatology. 2009;160(5):1040-7.
  12. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. Journal of the American Academy of Dermatology. 2013;69(5):729-35.
  13. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet (London, England). 2007;370(9583):272-84.
  14. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA dermatology. 2013;149(10):1180-5.
  15. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. Journal of the American Academy of Dermatology. 2011;65(1):137-74.
  16. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. Journal of the American Academy of Dermatology. 2001;45(4):487-98; quiz 99-502.
  17. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology. 2008;58(5):826-50.
  18. Schmitt J, Rosumeck S, Thomaschewski G, Sporbeck B, Haufe E, Nast A. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. The British journal of dermatology. 2014;170(2):274-303.
  19. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. Journal of the American Academy of Dermatology. 2010;62(1):114-35.
  20. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. The British journal of dermatology. 1996;135(4):533-7.
  21. Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiology & behavior. 2000;70(5):567-71.